MedPath

To see whether advice about sleeping practices along with medicines can reduce sleeplessness in patients with cancer receiving treatment

Phase 3
Conditions
Health Condition 1: G470- Insomnia
Registration Number
CTRI/2024/07/071467
Lead Sponsor
Jawaharlal Institute of Postgraduate Medical Education Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosis of cancer

On curative chemotherapy beyond cycle 1

Insomnia as per scale of at least 15

Presence of insomnia after cycle 1 within 4 weeks prior to enrolment

Normal organ function

able to understand tamil or english

Exclusion Criteria

Already on anti insomnia medication

known psychiatric illnesses

Known sleep disorders on medications

patients with hematological cancers

Primary brain tumors or brain metastasis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insomnia status assessed by the ISI scoreTimepoint: Insomnia status assessed by the ISI score
Secondary Outcome Measures
NameTimeMethod
Quality of lifeTimepoint: 6 weeks;Symptom severity scoreTimepoint: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath